Results 21 to 30 of about 3,875 (181)

SETBP1 (SET binding protein 1) [PDF]

open access: yesAtlas of Genetics and Cytogenetics in Oncology and Haematology, 2013
Review on SETBP1 (SET binding protein 1), with data on DNA, on the protein encoded, and where the gene is implicated.
Cristóbal, I   +2 more
openaire   +4 more sources

SETBP1dysregulation in congenital disorders and myeloid neoplasms [PDF]

open access: yesOncotarget, 2017
Myeloid malignancies are characterized by an extreme molecular heterogeneity, and many efforts have been made in the past decades to clarify the mechanisms underlying their pathogenesis. In this scenario SET binding protein 1 (SETBP1) has attracted a lot of interest as a new oncogene and potential marker, in addition to its involvement in the Schinzel ...
COCCARO, NICOLETTA   +5 more
openaire   +5 more sources

The landscape of SETBP1 gene expression and transcription factor activity across human tissues.

open access: yesPLoS ONE
The SET binding protein 1 (SETBP1) gene encodes a transcription factor (TF) involved in various cellular processes. Variants in SETBP1 can result in three different diseases determined by the introduction (germline vs.
Jordan H Whitlock   +4 more
doaj   +4 more sources

Expression and regulation of SETBP1 in the song system of male zebra finches (Taeniopygia guttata) during singing [PDF]

open access: yesScientific Reports
Rare de novo heterozygous loss-of-function SETBP1 variants lead to a neurodevelopmental disorder characterized by speech deficits, indicating a potential involvement of SETBP1 in human speech.
Dana Jenny Grönberg   +5 more
doaj   +6 more sources

Identification of SETBP1 Mutations by Gene Panel Sequencing in Individuals With Intellectual Disability or With “Developmental and Epileptic Encephalopathy”

open access: yesFrontiers in Neurology, 2020
SETBP1 mutations are associated with the Schinzel-Giedion syndrome (SGS), characterized by profound neurodevelopmental delay, typical facial features, and multiple congenital malformations (OMIM 269150).
Elisa Bettella   +2 more
exaly   +3 more sources

Prognostic significance of SETBP1 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia, and chronic neutrophilic leukemia: A meta-analysis.

open access: yesPLoS ONE, 2017
ObjectivesThis meta-analysis investigates the prognostic effect of SET binding protein 1 (SETBP1) mutations in patients with myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), or chronic neutrophilic leukemia (CNL).MethodsEligible ...
Li-Hong Shou   +7 more
doaj   +2 more sources

Recurrent SETBP1 mutations in atypical chronic myeloid leukemia [PDF]

open access: yesNature Genetics, 2012
Atypical chronic myeloid leukemia (aCML) shares clinical and laboratory features with CML, but it lacks the BCR-ABL1 fusion. We performed exome sequencing of eight aCMLs and identified somatic alterations of SETBP1 (encoding a p.Gly870Ser alteration) in two cases.
PIAZZA, ROCCO GIOVANNI   +27 more
openaire   +5 more sources

SETBP1 mutations as a biomarker for myelodysplasia /myeloproliferative neoplasm overlap syndrome [PDF]

open access: yesBiomarker Research, 2017
Myelodysplasia (MDS) /myeloproliferative neoplasm (MPN) overlap syndrome has been described since the 2001 WHO classification as disorders that have both proliferative and dysplastic changes simultaneously.
Katherine Linder   +2 more
doaj   +3 more sources

Atypical chronic myeloid leukemia: From diagnosis to molecular features and therapeutic options [PDF]

open access: yesHemaSphere
Atypical chronic myeloid leukemia (aCML) is a rare form of myelodysplastic (MDS)/myeloproliferative neoplasm (MPN) overlap disorder characterized by neutrophilic leukocytosis with circulating immature myeloid cells (IMC), frequent hepatosplenomegaly, and
Alessandra Iurlo   +3 more
doaj   +2 more sources

Identification of a Novel <i>KRAS::ETNK1</i> Fusion Transcript in a Myelodysplastic/Myeloproliferative Overlap Syndrome With Eosinophilia: A Case Report. [PDF]

open access: yesEJHaem
ABSTRACT This work describes, to our knowledge, the first reported case of a patient with an MDS/MPN overlap syndrome harboring a novel KRAS::ETNK1 fusion transcript. The disease initially presented with eosinophilia, megakaryocyte expansion, mast cell infiltration, and a background of typical MDS/MPN‐associated mutations (ASXL1, TET2, EZH2, BCOR, and ...
Caledec M   +17 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy